Shengmeng Peng
P.R. China
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Targeting TPX2-dependent lineage plasticity by CDK4/6 inhibition reverses therapy resistance in neuroendocrine bladder carcinoma.
Journal: Cell reports. Medicine
Published: December 05, 2025
ANXA2-mediated Phagocytosis Generates AR+ Macrophages to Confer Enzalutamide Resistance in Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 02, 2025
Thrombosis-related gene signature predicts prostate cancer recurrence and immune therapy: insights from retrospective cohorts, bioinformatics, and experimental validation.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: July 24, 2025
Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 15, 2025
Correction: TSPAN18 facilitates bone metastasis of prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 11, 2025
Engineering CRISPR System-Based Bacterial Outer Membrane Vesicle Potentiates T Cell Immunity for Enhanced Cancer Immunotherapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: January 22, 2025
FOXA1-dependent PUS1 regulates EIF3b stability in a non-enzymatic pathway mediating prostate cancer bone metastasis.
Journal: International journal of biological sciences
Published: July 13, 2024
PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 31, 2024
SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasis.
Journal: MedComm
Published: May 23, 2024
Establishment of a prognostic model to predict chemotherapy response and identification of RAC3 as a chemotherapeutic target in bladder cancer.
Journal: Environmental toxicology
Published: April 24, 2023
A clinically practical model for the preoperative prediction of lymph node metastasis in bladder cancer: a multicohort study.
Journal: British journal of cancer
Published: March 05, 2023
Last Updated: 09/26/2026